OTC Markets EXMKT - Delayed Quote USD

GeneLink, Inc. (GNLKQ)

Compare
0.0001 0.0000 (0.00%)
At close: October 30 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2008 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Bernard L. Kasten Jr., Ph.D., M.D. Executive Chairman, Chief Executive Officer, President and Member of Scientific Advisory Board 23.72k -- 1946
Dr. Robert P. Ricciardi Founder, Chief Science Officer, Treasurer, Secretary, Director & Member of Scientific Advisory Board 30k -- 1947
Mr. Michael G. Smith COO & Interim CFO -- -- 1966

GeneLink, Inc.

8240 Exchange Drive
Suite C1
Orlando, FL 32809
United States
407-680-1150 https://www.genelinkbio.com
Sector:?
Healthcare
Industry:?
Biotechnology

Description

GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.

Corporate Governance

GeneLink, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events